JP Morgan resist the markets fall


Nikkei 225


▼ -341.97 / -1.16%

SSE Composite


▲ +12.96 / +0.42%



▲ +2,049.06 / +1.83%

Straits Times


▼ -23.86 / -0.78%



▲ +743.47 / +1.64%

Dow Jones


▲ +576.02 / +1.94%

DAX 30


▲ +211.22 / +1.70%



▲ +491.01 / +0.85%

FTSE 100


▲ +61.45 / +0.90%

JSE Top 40


▲ +1,793.77 / +3.10%

Last Week’s Highlights

JP Morgan’s better-than-expected results

JP Morgan Chase presented its results for the third quarter of the year. The banking entity generated revenues of 32.7 billion dollars, an increase of 10.4% year-on-year, and exceeded the figure estimated by several analysts of 24.32 billion dollars. In the same period last year, JPM had earnings per share of $3.74. Analysts speculated that the profit for the third quarter of this year would be $2.90 per share; however, the figure was exceeded and reached $3.12 per share. Looking ahead, there is optimism regarding JP Morgan’s stock. Specialists give it a “moderate buy” rating, and the average price forecast for the company’s shares is $135.25, implying an upside potential of 23.6% at current levels.

Amazon’s Prime Day fails

Amazon made an effort to attract new customers with Prime Day, however the figures are not so positive. With Prime Day held on October 11 and 12, for the first time Amazon had discounted sales twice in one year, the other being in July. The results were not what the e-commerce company expected, as it was just like any other day. Amazon Worldwide Stores CEO, Doug Herrington, stated that Prime Day is just the beginning of what the company plans. “Customers will find millions of must-have deals all season long that will help them continue to save money on gifts for their loved ones,” he concluded. According to company reports, there were more than 100 million items sold in this week’s Prime sale, a figure that was down from July’s sales of more than 300 million items.

Coming Up This Week

The booster shot against Omicron

Pfizer claims that the new vaccine booster for the Omicron variant has better protection compared to the original vaccine. The US drugmaker, together with its partner BioNTech SE, presented positive results from the Phase 2/3 booster dose study for its bivalent Omicron variant vaccine. An increase in neutralizing antibodies against substrates was found compared to pre-booster levels.Pfizer President and CEO Albert Bourla said, “We are pleased to see encouraging responses just one week after vaccination in young and older adults. These early data suggest that our bivalent vaccine is expected to provide better protection against currently circulating variants than the original vaccine and potentially help curb future increases in cases this winter.” In addition, Pfizer is trying to increase its demand for vaccines through a partnership with Marvel comics to raise awareness of the importance and benefits of vaccination.

Ad-supported Netflix to come in November

Netflix announced that as of November it will start streaming plans with advertising for a price of $6.99 per month. It will be the cheapest plan of this platform, with which the company expects to recover several customers lost in recent times. The plan will be available in 12 countries and will be launched progressively between November 1 and 10. Subscribers to this plan will not have benefits such as downloading content or high resolution in series and movies. According to a report by The Wall Street Journal, each ad will last between 15 and 30 seconds, and about five minutes of ads will appear every hour before and during the playback of any content. The very strong competition in this market, and the current global economic situation create a complicated scenario for Netflix, and its shares have already lost 61.1% of their value.

All information provided was collected up to the last business day of the previous week of the release of this NewsFlight. The purpose of NewsFlight is to summarize and make accessible information on a variety of topics within the world of investing and personal finance, and thus cannot be considered formal research or reports. All sources utilized to compile the NewsFlight newsletter are considered trustworthy by the FlexInvest team. FlexInvest is not affiliated with and does not receive remuneration from the news sources used to compile NewsFlight. As well, any images or logos incorporated into the NewsFlight newsletter are not necessarily property of FlexInvest and may solely be included to provide context for the news covered. NewsFlight should not be taken as advice to sell or buy securities or to make any investment. When investing in securities or other financial products, there is always the potential to lose money or asset value. FlexInvest recommends that its users consider their investment objectives and risks before investing. Additionally, any projections or analysis made by authors of NewsFlight cannot be considered as a promise of future trends or returns. Opinions expressed in NewsFlight are not representative of FlexInvest.

Market News

Wall Street posted its falls while inflation rises. Banking firms such as JP Morgan Chase & Co, Morgan Stanley, Citigroup Inc and Wells Fargo & Co said they have seen declines in net income as investment banking activity was affected and lenders set aside more funds to cover loan defaults.

Similarly, shares of major US indexes declined on Friday as deteriorating inflation expectations increased fears that aggressive rate hikes by the Federal Reserve could trigger a recession. The Dow Jones index fell 0.64%, the S&P 500 was down 1.28% and the Nasdaq Composite lost 1.64%.

Wild Card

Oil is on the decline due to inflation and recession worries.

More things to sip on...

Apple card holders could soon increase savings and rewards.
UnitedHealth expects strong 2023 earnings as COVID costs ease.
Victoria’s Secret stock spiked last week.

Latest Market Insights